Key result
Evaluation of antihypertensive drug use in chronic kidney disease patients on hemodialysis showed that 100% of the prescribed doses were appropriate according to standard guidelines.
Why the study?
Accurate antihypertensive dosing in hemodialysis patients with chronic kidney disease is needed to ensure therapeutic effectiveness and minimize toxicity.
Observational (n=14)
No
In a small cohort of hemodialysis patients, antihypertensive dosing was found to be 100% appropriate, with furosemide being the most commonly prescribed agent.
Answers are grounded in this paper and cite their sources.
Antihypertensive dosing in hemodialysis patients warrants caution; Level 5 observational data leaves open optimal patterns.
Hypertension is common in patients with chronic kidney disease on hemodialysis and can be the main cause of death, so antihypertensive drugs are needed. Accurate antihypertensive dosage, especially for drugs that are excreted through the kidneys, is necessary to achieve therapeutic effectiveness and minimize the incidence of toxicity. This study aims to determine patient characteristics, drug use patterns, and appropriate use of antihypertensive doses. Observational research method with retrospective data collection based on outpatient medical records in January-December 2023 using purposive sampling. Of the total 14 patients, most patients were male (58.82%). Most patients were in the early elderly category (46-55 years) (50%). Based on the diagnosis of the disease with the highest percentage, stage 5 chronic kidney disease as the main diagnosis (100%), congestive heart failure as a secondary diagnosis (21.42%), hypertension as a comorbidity (57.14%), and anemia as a complication (100%). The monotherapy antihypertensive drug that is widely used is furosemide (64.28%). Meanwhile, the combination of antihypertensive drugs used was furosemide + telmisartan (7.14%). Evaluation of antihypertensive drugs use obtained 100% according to the dose.
No takes yet. Share an insight, caveat, or question.
Indriani et al. (2025) conducted an observational in Chronic kidney disease on hemodialysis (n=14). Antihypertensive drugs was evaluated on Appropriateness of antihypertensive drug dosage. Evaluation of antihypertensive drug use in chronic kidney disease patients on hemodialysis showed that 100% of the prescribed doses were appropriate according to standard guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: